News | December 27, 2024
Thyrocare secures NABL accreditation for its Labs
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
Thyrocare Technologies has reported total income of Rs. 179.97 crores during the period ended September 30, 2024
Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs. 30 crores during FY 2024 and Rs. 7 crores in Q1 FY 2025
Thyrocare Technologies has reported total income of Rs. 160.53 crores during the period ended June 30, 2024
The company has posted net profit of Rs.70.76 crores for the Financial Year ended March 31, 2024
Thyrocare Technologies has reported total income of Rs. 137.47 crores during the period ended December 31, 2023
Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023
The company has reported total income of Rs. 135.87 crores during the period ended June 30, 2023
In a bid to better leverage its clinical expertise and drive quality reporting across its centres, Thyrocare has added SigTuple’s AI100 to automate the microscopic review in its laboratories
The company has reported total income of Rs. 128.79 crores during the period ended June 30, 2022.
Subscribe To Our Newsletter & Stay Updated
